Cell-Penetrating Peptide-Modified Block Copolymer Micelles Promote Direct Brain Delivery via Intranasal Administration

被引:125
作者
Kanazawa, Takanori [1 ]
Taki, Hiroyuki [1 ]
Tanaka, Ko [1 ]
Takashima, Yuuki [1 ]
Okada, Hiroaki [1 ]
机构
[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Pharmaceut Sci, Lab Pharmaceut & Drug Delivery, Tokyo 1920392, Japan
关键词
biodistribution; brain tumors; cell penetrating peptide; intranasal brain delivery; micelles; CENTRAL-NERVOUS-SYSTEM; GENE DELIVERY; TRANSPORT; NANOPARTICLES; DRUGS; TAT;
D O I
10.1007/s11095-011-0440-7
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In order to develop non-invasive and effective nose-to-brain delivery of drugs, we synthesized Tat analog-modified methoxy poly(ethylene glycol) (MPEG)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymers through the ester bond. We evaluated the brain distribution of coumarin, acting as a model chemical, after intravenous or intranasal administration of MPEG-PCL. In addition, cellular uptake of coumarin by rat glioma cells transfected with coumarin-loaded MPEG-PCL or MPEG-PCL-Tat was determined. Finally, we determined the brain distribution and biodistribution after intranasal administration of coumarin-loaded MPEG-PCL-Tat. The amount of coumarin in the brain after intranasal administration was significantly higher than that after intravenous administration. In addition, cellular uptake of coumarin using MPEG-PCL was the lowest, while cellular uptake of coumarin using Tat-modified MPEG-PCL (MPEG-PCL-Tat) was higher than that of MPEG-PCL. Therefore, the brain distribution of coumarin administered using MPEG-PCL-Tat was significantly greater than that using MPEG-PCL. Then, the coumarin distribution after MPEG-PCL-Tat administration in non-targeted tissues (lung, liver, heart, kidney and spleen) was lower than that after coumarin administration without nanomicelles. We have demonstrated that utilization of nano-sized micelles modified with Tat can facilitate direct intranasal brain delivery.
引用
收藏
页码:2130 / 2139
页数:10
相关论文
共 16 条
[1]   Transport of nanoparticles across the rat nasal mucosa [J].
Brooking, J ;
Davis, SS ;
Illum, L .
JOURNAL OF DRUG TARGETING, 2001, 9 (04) :267-279
[2]  
CBTRUS, 2005, PRIM BRAIN TUM US ST
[3]  
Dhanda DS., 2005, Drug Delivery Technology, V5, P64
[4]   Intranasal Delivery to the Central Nervous System: Mechanisms and Experimental Considerations [J].
Dhuria, Shyeilla V. ;
Hanson, Leah R. ;
Frey, William H., II .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (04) :1654-1673
[5]   New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163 [J].
Hashizume, Rintaro ;
Ozawa, Tomoko ;
Gryaznov, Sergei M. ;
Bollen, Andrew W. ;
Lamborn, Kathleen R. ;
Frey, William H., II ;
Deen, Dennis F. .
NEURO-ONCOLOGY, 2008, 10 (02) :112-120
[6]   Is nose-to-brain transport of drugs in man a reality? [J].
Illum, L .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (01) :3-17
[7]   Transport of drugs from the nasal cavity to the central nervous system [J].
Illum, L .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 (01) :1-18
[8]   Effects of menstrual cycle on gene transfection through mouse vagina for DNA vaccine [J].
Kanazawa, T. ;
Takashima, Y. ;
Hirayama, S. ;
Okada, H. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 360 (1-2) :164-170
[9]   Nanoparticles for direct nose-to-brain delivery of drugs [J].
Mistry, Alpesh ;
Stolnik, Snjezana ;
Illum, Lisbeth .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 379 (01) :146-157
[10]   Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery [J].
Rajagopalan, Rukkumani ;
Xavier, Jennifer ;
Rangaraj, Nandini ;
Rao, Nalam Madhusudhana ;
Gopal, Vijaya .
JOURNAL OF GENE MEDICINE, 2007, 9 (04) :275-286